Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
274 studies found for:    "Scleroderma, Systemic"
Show Display Options
RSS Create an RSS feed from your search for:
"Scleroderma, Systemic"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement
Condition: Scleroderma, Systemic
Intervention: Drug: Mycophenolate mofetil
2 Completed Efficacy and Safety Study of GB-0998 for Treatment of Systemic Sclerosis
Condition: Scleroderma, Systemic
Intervention: Drug: High-dose intravenous immunoglobulin (Venoglobulin-IH)
3 Terminated Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis
Condition: Scleroderma, Systemic
Interventions: Drug: Thalidomide;   Drug: Placebo thalidomide
4 Recruiting A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis
Condition: Scleroderma, Systemic
Interventions: Drug: Nintedanib;   Drug: Placebo
5 Completed
Has Results
Imatinib in Systemic Sclerosis
Condition: Scleroderma, Systemic
Intervention: Drug: Imatinib mesylate
6 Recruiting Role of Circulating Cytotoxic Lymphocytes in Endothelial Cell Injury in Systemic Sclerosis
Condition: Scleroderma, Systemic
Intervention: Other: blood samples
7 Recruiting Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis
Condition: Scleroderma, Systemic
Interventions: Drug: Riociguat (Adempas, BAY63-2521);   Drug: Placebo
8 Not yet recruiting The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis
Condition: Scleroderma, Systemic
Intervention: Drug: bosentan
9 Unknown  Platelet Gel in Systemic Sclerosis
Condition: Scleroderma, Systemic
Intervention: Drug: Platelet Gel
10 Recruiting Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis
Condition: Scleroderma, Systemic
Interventions: Drug: Stromal Vascular fraction;   Drug: Ringer lactate
11 Completed Efficacy and Safety of Imatinib in Scleroderma
Conditions: Scleroderma, Localized;   Scleroderma, Systemic
Intervention: Drug: imatinib mesylate
12 Not yet recruiting Oral Manifestations of Systemic Sclerosis
Condition: Scleroderma, Systemic
Intervention: Radiation: Cone Beam Computed Tomography (CBCT)
13 Recruiting Scleroderma Registry & Repository at the Hospital for Special Surgery
Condition: Scleroderma
Intervention:
14 Unknown  Nilotinib in the Treatment of Systemic Sclerosis
Condition: Systemic Sclerosis
Intervention: Drug: Nilotinib (Tasigna)
15 Active, not recruiting Taking Charge of Systemic Sclerosis
Condition: Scleroderma
Interventions: Other: Internet-based self-management program;   Other: Scleroderma book
16 Completed Morbidity and Mortality Follow Up for the Scleroderma Lung Study
Condition: Scleroderma
Intervention: Other: Followup survey
17 Unknown  Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis
Condition: Systemic Sclerosis
Intervention: Drug: Imatinib Mesylate
18 Completed Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis
Condition: Systemic Sclerosis
Intervention:
19 Recruiting Campath-1h Phase I/II Pilot Trial as Immunoablative Therapy for Refractory Systemic Sclerosis
Condition: Scleroderma
Intervention: Drug: Campath
20 Unknown  High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis
Condition: Scleroderma, Diffuse
Intervention: Drug: N-acetylcysteine (NAC)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.